New drug targets Hard-to-Treat cancers in major trial
NCT ID NCT06660654
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new drug called raludotatug deruxtecan (R-DXd) in 200 adults with advanced or spreading solid tumors, including certain ovarian, cervical, endometrial, bladder, and kidney cancers. The goal is to see if the drug can shrink tumors or stop them from growing. Participants must have tumors that have gotten worse after prior treatment. This is not a cure, but aims to control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AO per lEmergenza Cannizzaro
Catania, 95126, Italy
-
Aichi Cancer Centre
Nagoya, 464-8681, Japan
-
Asan Medical Center
Seoul, 05505, South Korea
-
Astera Cancer Care
East Brunswick, New Jersey, 08816, United States
-
Azienda Ospedaliera S Maria
Terni, 05100, Italy
-
Cario - Centre Armoricain de Radiothérapie, Imagerie Médicale Et Oncologie
Plérin, 22190, France
-
Centre Georges-François Leclerc
Dijon, 21079, France
-
Centre Leon Berard
Lyon, 69008, France
-
Centre Oscar Lambret
Lille, 59 000, France
-
Clinical Research Alliance
Westbury, New York, 11590, United States
-
Federico II Hospital
Naples, 80131, Italy
-
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, 40121, Italy
-
François Baclesse Center
Caen, 14000, France
-
Grp Hsp Diac Croix Saint Simon
Paris, 75012, France
-
Gustave Roussy
Villejuif, 94800, France
-
Herlev og Gentofte Hosp
Copenhagen, 2100, Denmark
-
Hospital 12 Octubre
Madrid, 28041, Spain
-
Hospital Universitario Virgen de la Victoria
Málaga, 29010, Spain
-
Hospital Universitario de A Coruña
A Coruña, 15006, Spain
-
Hospital de Sant Pau
Barcelona, 08041, Spain
-
Hunan Cancer Hospital
Changsha, 410013, China
-
Hyogo Cancer Center
Akashi, 13-70, Japan
-
IRCCS Dino Amadori - IRST
Meldola, 47014, Italy
-
IRCCS San Raffaele
Milan, 20132, Italy
-
Ico - Site René Gauducheau
Saint-Herblain, 44805, France
-
Institut Claudius Regaud
Toulouse, 31100, France
-
Irccs Ospedale San Martino
Genova, 16132, Italy
-
Md Anderson Cancer Centre
Madrid, 28033, Spain
-
Memorial Sloan-Kettering Cancer Center
New York, New York, 10065, United States
-
National Cancer Center
Goyang-si, 10408, South Korea
-
National Cancer Center Hospital
Chūōku, 104-0045, Japan
-
National Cancer Center Hospital East
Kashiwa, 277-8577, Japan
-
National Hospital Organization Kyushu Cancer Center
Fukuoka, 811-1395, Japan
-
Northside Hospital
Marietta, Georgia, 30060, United States
-
Osaka International Cancer Institute
Osaka, 541-8567, Japan
-
Saitama Medical University International Medical Center
Hidaka, 1397-1, Japan
-
Samsung Medical Center
Seoul, 06351, South Korea
-
Severance Hospital
Seoul, 03722, South Korea
-
Shanghai Cancer center
Shanghai, 200000, China
-
The Cancer Institute Hospital of Jfcr
Kōtoku, Japan
-
The Clínica Universidad de Navarra Madrid
Madrid, 28027, Spain
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
UZ Leuven Gynaec onco
Leuven, 3000, Belgium
-
University of Michigan Comprehensive Cancer Center Michigan Medicine
Ann Arbor, Michigan, 48109, United States
-
Vall d'Hebron University Hospital
Barcelona, 08035, Spain
-
West Cancer Center and Research Institute
Germantown, Tennessee, 38138, United States
-
Women's Cancer Care Associates
Albany, New York, 12208, United States
-
ZAS Sint-Augustinus
Wilrijk, 2610, Belgium